Clinical trials
Phase 2/3 Lupus Erythematosus, Systemic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 5 |
| Recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ain Shams University | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Assiut University | 1 |
| Biogen | 1 |
| Boston Children's Hospital | 1 |
| Bristol-Myers Squibb | 1 |
| Buddhist Tzu Chi General Hospital | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Chinese SLE Treatment And Research Group | 1 |
| EMD Serono | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 20 |
| Nephritis | 2 |
| Vasculitis | 2 |
| Arthritis | 1 |
| Arthritis, Juvenile | 1 |
| Arthritis, Rheumatoid | 1 |
| COVID-19 | 1 |
| Communicable Diseases | 1 |
| Connective Tissue Diseases | 1 |
| Crohn Disease | 1 |
Trials
Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.